Injectable lipid emulsions-advancements, opportunities and challenges.
about
Pharmaceutical point of view on parenteral nutritionNanoemulsions in translational research-opportunities and challenges in targeted cancer therapyTreatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systemsVitamin D3-Loaded Nanostructured Lipid Carriers as a Potential Approach for Fortifying Food Beverages; in Vitro and in Vivo Evaluation.A cationic nanoemulsion for the delivery of next-generation RNA vaccines.The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesPreparation of intravenous cholesterol tracer using current good manufacturing practicesStructure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agentsExploring the effect of intravenous lipid emulsion in acute methamphetamine toxicity.Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.Alternative lipid emulsions in the critically ill: a systematic review of the evidence.Lipid Rescue - Efficacy and Safety Still Unproven.The Emerging Role of Nanotechnology in Cell and Organ Transplantation.Propofol in the treatment of refractory migraine headaches.Mechanism of activity and toxicity of Nystatin-Intralipid.Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.Effects on varying intravenous lipid emulsions on the small bowel epithelium in a mouse model of parenteral nutrition.Screening of Lipid Composition for Scalable Fabrication of Solvent-Free Lipid Microarrays.Computed Tomography-Guided Screening of Surfactant Effect on Blood Circulation Time of Emulsions: Application to the Design of an Emulsion Formulation for Paclitaxel
P2860
Q26820881-133509AE-7D11-41AB-9A4D-457C54A0EFA9Q26858849-418C7F3C-FC76-449B-81AC-5101123E612AQ27025606-25326FDF-CB8D-4F12-9011-2536091EC6F1Q33664092-5347AFA1-AD90-40C2-9FF2-ADF636944DCEQ35600305-B2DF1E08-671A-4ADB-A41A-9FFC658F8129Q35994365-97F8BDCD-DEF1-4EB3-B0D1-654A2CB9F44FQ36307267-AD4F1026-2873-43A4-A1C8-4E5D322D927BQ36672143-E8364CA3-F67C-4579-B43C-7EAD022FE922Q37683745-162A2EB5-5D80-4EFC-AFED-53B169D1A7FAQ38077678-FC31ED88-783B-4747-998E-357D0D5130BBQ38118120-16A3CB9F-4FA8-4194-9C1D-42F4431C8916Q38823166-C7692F55-D4E7-4C90-92A8-36A6DEFD33DAQ38852662-FB6907D4-E466-43B8-B0A3-F57F0206D17EQ38907698-15FB077B-6308-4A64-895B-A2D0D1F3E0EDQ39255260-2961354A-36DA-48F7-8BAE-0A2230EDF793Q39875387-A96D654D-7183-4E84-8377-F149160CEFB3Q40043040-CBC16D8F-D8C6-4272-94E8-B42D07CA8191Q50916717-96E20EC4-C8AA-446F-8110-CFFE6D159452Q55085070-BA405196-428F-4998-A843-25B7315510A9Q59115809-FF20F72C-BE1B-4E68-B46C-D2DE553C16AD
P2860
Injectable lipid emulsions-advancements, opportunities and challenges.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Injectable lipid emulsions-advancements, opportunities and challenges.
@en
Injectable lipid emulsions-advancements, opportunities and challenges.
@nl
type
label
Injectable lipid emulsions-advancements, opportunities and challenges.
@en
Injectable lipid emulsions-advancements, opportunities and challenges.
@nl
prefLabel
Injectable lipid emulsions-advancements, opportunities and challenges.
@en
Injectable lipid emulsions-advancements, opportunities and challenges.
@nl
P2093
P2860
P1433
P1476
Injectable lipid emulsions-advancements, opportunities and challenges.
@en
P2093
Ketan Hippalgaonkar
Soumyajit Majumdar
Viral Kansara
P2860
P2888
P304
P356
10.1208/S12249-010-9526-5
P407
P577
2010-10-26T00:00:00Z
P5875
P6179
1042570661